Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Management of Hematologic Malignancies
  • Language: en
  • Pages: 527

Management of Hematologic Malignancies

Hematologic malignancies were the first human cancers to be studied in depth at the molecular level, and recent years have seen important advances in treatment. This comprehensive reference book covers the full range of hematologic malignancies, including all subtypes of leukemias, lymphomas, and plasma cell dyscrasias. Authored by internationally known experts, each chapter emphasizes diagnostic work-up, staging, and therapeutic approaches. Up-to-date hematopathology, treatment, and outcomes data are presented in a way which is directly applicable to patient care. Highly illustrated with color images, graphs, flowcharts and treatment algorithms, the book is perfect for quick clinical reference as well as providing detailed reference lists for further study. With its authoritative and practical focus and visually stimulating presentation, this is a key text for hematology and oncology fellows, physicians, oncology nurses, physician assistants and other healthcare workers in the field of oncology.

Principles and Practice of Cancer Infectious Diseases
  • Language: en
  • Pages: 581

Principles and Practice of Cancer Infectious Diseases

Principles and Practice of Cancer Infectious Diseases is a comprehensive and insightful work dedicated to elucidating the problem of infections in cancer patients. This essential volume reviews common and less often encountered infections, while establishing the difficulties behind preventing, diagnosing, and treating infectious diseases in cancer patients. Key sections are devoted to the presentation of clinical symptoms and the identification of major etiologic agents. A cadre of leading clinicians provide a detailed assessment of the risk factors for various infections, critical strategies in preventing and managing infections, and study of the interactions between the pathogen and host's immune function and inflammatory response. With its in-depth knowledge and concise treatment of the distinct facets of infections in cancer patients, this volume is an indispensible tool for all infectious disease specialists and clinical oncologists.

Lymphomas
  • Language: en
  • Pages: 210

Lymphomas

This work for oncologists and cancer biologists provides eight chapters on the evolving role of established therapies as well as pathway-directed agents, within the context of the emerging paradigm of personalized lymphoma treatment. The disease specific chapters describe signaling pathways central to disease pathology, but also emphasize the biological heterogeneity of the entities currently recognized by the WHO Classification and stress the importance of this heterogeneity when considering treatment choices. The book examines new and emerging therapies for Hodgkin and non-Hodgkin lymphoma, T-cell lymphoma, indolent lymphoma, mantle cell lymphoma, and aggressive B-cell lymphoma. Treatments described include autologous hematopoietic stem cell transplantation, allogenic stem cell transplantation, and non-transplant-based salvage therapy. Sweetenham teaches medicine at UCSD Nevada Cancer Institute in Las Vegas. Annotation ©2012 Book News, Inc., Portland, OR (booknews.com).

Precision Cancer Therapies, Volume 1
  • Language: en
  • Pages: 516

Precision Cancer Therapies, Volume 1

A Thorough Compilation of the Many Scientific Breakthroughs in the Ongoing Development of Precision Cancer Therapies Related to Lymphoma Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice focuses on lymphoma, an area which has seen a remarkable number of breakthroughs in the ongoing development of precision cancer therapies. Each section on a specific biology or class of drugs has an introductory chapter written by an authority in the field, exclusively focused on the science and its relevance to cancer biology. This approach addresses the need for scientists, physicians, and the private sector to understand the broader context of the extrao...

Battling and Beating Cancer
  • Language: en
  • Pages: 375

Battling and Beating Cancer

“Battling And Beating Cancer - The Cancer Survival Book” is an inspiring story of a couple fighting cancer together. It provides a poignant look at cancer from the perspectives of patient and caregiver - covering the highs and lows from diagnosis, to surgery, to chemotherapy, to radiation, to follow-up, to fighting back for people impacted by cancer. It also serves as an important survival resource for patients and families battling cancer – loaded with checklists, information, tips, and insights. It even outlines a strategy and national call to action for curing cancer. This is a compelling story of general interest and a must read for the millions of Americans impacted by cancer.

Lymphoma Cancer Recovery
  • Language: en
  • Pages: 72

Lymphoma Cancer Recovery

Lymphoma can be beaten. 7 survivors tell how they beat lymphoma, some even at stage 4. GOOD NEWS FOR LYMPHOMA SUFFERERS AND THEIR FAMILIES……. LYMPHOMA CANCER CAN BE BEATEN! In these breathtaking stories of courage and survival, 7 lymphoma survivors tell their stories, each one revealing: “How I Survived Lymphoma …. and How YOU Can Too!” Read on to discover the other uplifting stories in this book of lymphoma survivors John’s story: “What made me a survivor I believe, was that I took an active part in dealing with the illness, instead of just letting the whole process happen to me. I learnt that you have to participate in the healing journey, big time.” At first John relied al...

Hodgkin's Lymphoma
  • Language: en
  • Pages: 286

Hodgkin's Lymphoma

Hodgkin's Lymphoma is the book consisting of 11 chapters: Recent insights into the biology of Hodgkin's lymphoma, including historical aspects, epidemiology, pathophysiology, genetic defects, and prognostic indicators are explained in the intro chapters. After a translational chapter from tumor microenvironment to immunotherapeutic approach, treatment of early stage, advanced, and refractory Hodgkin's lymphoma are explained in the following chapters. MALT lymphoma and adverse effects of chemotherapy and radiotherapy in the affected patients are discussed in the subsequent chapters, while the final chapter is focused on survivorship in Hodgkin's lymphoma. The book is intended to present recent advances in the pathophysiology of Hodgkin's lymphoma as well as practical approach to diagnosis and management in clinical practice, which is hoped to be welcomed by the physicians, who wish to learn more about Hodgkin's lymphoma.

New York Magazine
  • Language: en
  • Pages: 122

New York Magazine

  • Type: Magazine
  • -
  • Published: 1995-04-24
  • -
  • Publisher: Unknown

New York magazine was born in 1968 after a run as an insert of the New York Herald Tribune and quickly made a place for itself as the trusted resource for readers across the country. With award-winning writing and photography covering everything from politics and food to theater and fashion, the magazine's consistent mission has been to reflect back to its audience the energy and excitement of the city itself, while celebrating New York as both a place and an idea.

El Don de Si
  • Language: es
  • Pages: 228

El Don de Si

  • Type: Book
  • -
  • Published: 1997-03-01
  • -
  • Publisher: Unknown

None

Bortezomib in the Treatment of Multiple Myeloma
  • Language: en
  • Pages: 183

Bortezomib in the Treatment of Multiple Myeloma

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.